InvestorsHub Logo
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
Swampdude Free
10/23/19 7:36 AM
profile icon
Swampdude Free
10/21/19 10:31 AM
profile icon
pauljack13 Free
04/11/19 7:34 PM
profile icon
yankees18 Free
04/11/19 5:25 PM
profile icon
stephenbolder Free
03/22/19 10:17 PM
profile icon
StockRacer87 Free
03/12/19 8:40 AM
profile icon
AnthonyS Free
03/12/19 6:58 AM
profile icon
INTL Free
03/11/19 12:48 PM
profile icon
INTL Free
03/11/19 9:18 AM
profile icon
Acen176 Free
03/10/19 8:01 PM
profile icon
INTL Free
03/10/19 7:55 PM
profile icon
Acen176 Free
03/10/19 3:07 PM
profile icon
OZZE Free
03/10/19 3:03 PM
profile icon
Acen176 Free
03/10/19 1:05 PM
profile icon
OZZE Free
03/10/19 12:32 PM
profile icon
Acen176 Free
03/09/19 12:56 PM
profile icon
INTL Free
03/08/19 6:39 PM
profile icon
ClayTrader Free
03/08/19 5:57 PM
profile icon
dipANDrip Free
03/08/19 2:55 PM
profile icon
10bags Free
02/09/19 11:25 AM
profile icon
strongstock Free
01/26/19 6:00 PM
profile icon
crudeoil24 PremiumMember
01/03/19 9:19 AM
profile icon
crudeoil24 PremiumMember
01/03/19 9:16 AM
profile icon
ClayTrader Free
12/14/18 5:52 PM
profile icon
EL CHAPO Terminated
12/14/18 1:32 PM
profile icon
EL CHAPO Terminated
12/14/18 1:14 PM
profile icon
EL CHAPO Terminated
12/14/18 1:09 PM
profile icon
Stocklearner Free
12/14/18 12:41 PM
profile icon
EL CHAPO Terminated
12/14/18 12:38 PM
profile icon
europtiger Free
12/14/18 12:05 PM
profile icon
EL CHAPO Terminated
12/14/18 11:58 AM
profile icon
EL CHAPO Terminated
12/14/18 11:48 AM
profile icon
europtiger Free
12/14/18 10:40 AM
profile icon
EL CHAPO Terminated
12/14/18 9:37 AM
profile icon
EL CHAPO Terminated
12/14/18 9:35 AM
profile icon
yankees18 Free
12/14/18 9:34 AM
profile icon
EL CHAPO Terminated
12/14/18 9:14 AM

Alliqua Inc fka ALQA RSS Feed

Followers
66
Posters
250
Posts (Today)
0
Posts (Total)
4871
Created
05/22/06
Type
Free
Moderators



Headquartered in New York, Alliqua, Inc., (OTCBB:ALQA) is a biomedical company focused on the development, manufacturing and marketing of its own proprietary products, utilizing its existing technology portfolio. It intends to pursue projects in the fields of active ingredient and transdermal drug delivery, as well as advanced wound care.

 

Alliqua's core transdermal delivery technology platform is designed to deliver drugs and other beneficial ingredients through the skin.  Transdermal delivery has multiple advantages over conventional oral and injection delivery including:


  • Avoidance of hepatic first pass metabolism causing less stress on the liver;
  • Non-invasive nature;
  • Improved patient compliance;
  • Discontinuation of administration by removal of the system;
  • Lower dosage;
  • No dependence on different metabolic rates of individuals; and
  • No interaction with the gastrointestinal system.

In addition, Alliqua's  patch technology can be utilized for the delivery of many drugs, including various proteins that have, until now, necessitated injections or intravenous infusions.

Alliqua intends to capitalize on its technology's other intrinsic benefits in various market verticals in the healthcare industry, including: wound healing, medical diagnostics and cosmeceuticals.


 

         


http://alliqua1.nextmp.net/about.html
http://www.aquamedinc.net/
http://googlerankingchecb03.unblog.fr/2012/08/13/gold-keyword-rank-checker-when-damp-emits-ions/
http://www.hepalifebiosystems.com/press-releases.php


 


 

Technology


Alliqua, through its wholly owned subsidiary AquaMed, develops, manufactures and markets electron-beam cross-linked sheet gels for use as transdermal delivery of medication, topical application of non-prescription drugs, wound/burn dressings with and without active ingredients, components in certain medical devices, treatments, cosmetics and other commercial products.

Hydrogels are gel-like or colloidal substances made of water and solids.  They can be created chemically (through a combination of ultra violet cross-linking and chemical interface), or by mixing polymer and water, and then exposing it to an electron beam creating a "sheet" of water. Alliqua believes that its hydrogels have a competitive advantage, in part due to the following product characteristics: painless adhesion to the human body, stability of form and composition, purity, reproducibility (manufacturing high quality product on a consistent basis), compatibility with active ingredients, and high water content.

Many of the products of Alliqua's competition feature physical characteristics which Alliqua believes are less desirable than its own hydrogels
 




Investor relations

Alliqua Inc.
850 3rd Avenue
Suite 1801
New York, NY 10022
646.218.1450

.

Products

Subsidiary Products
Alliqua Biomedical PHN Patch
  Hydress + Plus
  Hydress
Aquamed Technologies Contract Manufacturing Services
  Electrode Gel
  Sheet Hydrogels
HepaLife Biosystems HepaMate®

Alliqua is currently servicing the medical components marketplace through it Aquamed Technologies, Inc. subsidiary. It is also developing finished products for commercialization under its own brand names. The following table lists the various product in commercialization and development:

 

RECENT HEADLINES


Thursday, November 15, 2012

Wednesday, November 14, 2012

Tuesday, November 13, 2012

Wednesday, October 3, 2012

Wednesday, August 22, 2012

Thursday, August 16, 2012

Tuesday, August 14, 2012

Thursday, August 2, 2012

Tuesday, June 5, 2012

Thursday, May 24, 2012

CHARTS : 60 minutes - Daily - Weekly

 




 
Board Info
Posts Today
0
Posts (Total)
4871
Posters
250
Moderators
New Post